Visit Us at Booth 272


April 1-4, 2024 | Washington DC

Join us at the World Vaccine Congress Meeting in Washington D.C. happening from April 1-4. We are excited to showcase our preclinical vaccine development services including, protocol development, toxicology studies, in vivo options, immunogenicity testing; immunoassays, stability testing and more at booth 272.

Pre-book a meeting time with us, or stop by Booth 272,  to explore potential collaborations, and discover how our experience with animal models makes us the perfect partner to help study the effectiveness of new drugs, test for toxicity, and validate biomarkers. 

We look forward to meeting you in Washington D.C.!

Learn More About Noble’s Infectious Diseases Services:

Preclinical Vaccine Development Services

Protocol Development

  • Experienced in conventional and nucleic acid vaccines
  • Adjuvant testing and selection

In vivo Options

  • Rodents
  • Guinea Pigs
  • Rabbits
  • Ferrets
  • Large animals

Challenge-protection Studies

  • Clinical observations
  • In vitro determinations

Toxicology Studies

  • Single-dose and repeat-dose
  • Acute, sub-chronic, and chronic
  • Biodistribution

Immunogenicity Testing

  • Immunization and boost
  • Pre- and post-injection sample collection
  • Serology

Related Services

  • Immunoassays
  • Viral & bacterial neutralization
  • Vaccine stability testing
  • Custom antibody production

Meet the Noble Attendees

See Us at Booth 272

Todd Parsley, Ph.D.

Director of Infectious Diseases

Haimi Shiferaw

Client Services Representative

Raj Binjawadagi

Study Director
Infectious Diseases and Vaccines

Noble Life Sciences, is a global preclinical CRO dedicated to innovation and scientific discovery. With a proven track record in navigating the complexities of preclinical research, our dedicated team is poised to be your strategic partner in advancing your scientific initiatives, including vaccine development.

The World Vaccine Congress is the largest, most established meeting dedicated to vaccines. From basic research to commercial manufacture, this one meeting covers the whole vaccine value chain where science, government and manufacturers all come together to create groundbreaking progress. We welcome one-on-one meetings to connect with fellow industry professionals.

Visit Us at Booth 272


April 1-4, 2024 | Walter Convention Center in Washington DC